Preferred Label : aclidinium bromide;
MeSH note : a long-acting, inhaled antimuscarinic; in phase I trial 8/2008;
MeSH synonym : (3R)-3-((hydroxy(di-2-thienyl)acetyl)oxy)-1-(3-phenoxypropyl)-1-azoniabicyclo(2.2.2)octane
bromide;
Is substance : O;
UNII : UQW7UF9N91;
InChIKey : XLAKJQPTOJHYDR-QTQXQZBYSA-M;
Origin ID : C542859;
UMLS CUI : C2699758;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3192405/fr/eklira-genuair
2020
false
false
false
France
aclidinium bromide
insurance, health, reimbursement
treatment outcome
administration, inhalation
aclidinium bromide
cholinergic antagonists
adult
bronchodilator agents
pulmonary disease, chronic obstructive
evaluation of the transparency committee
tropanes
---
https://www.has-sante.fr/jcms/p_3192402/fr/duaklir-genuair
2020
false
false
false
France
drug combinations
formoterol and aclidinium bromide
insurance, health, reimbursement
treatment outcome
administration, inhalation
aclidinium bromide
muscarinic antagonists
Formoterol Fumarate
adrenergic beta-2 receptor agonists
bronchodilator agents
adult
pulmonary disease, chronic obstructive
Product containing only aclidinium and formoterol in pulmonary dose form (medicinal
product form)
evaluation of the transparency committee
tropanes
---
http://www.has-sante.fr/portail/jcms/c_2621462/fr/duaklir-genuair
2016
false
France
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
Formoterol Fumarate
formoterol and aclidinium bromide
insurance, health, reimbursement
evaluation of the transparency committee
tropanes
tropanes
administration, inhalation
adult
bronchodilator agents
treatment outcome
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
---
http://www.has-sante.fr/portail/jcms/c_2621483/fr/brimica-genuair
2016
false
France
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
evaluation of the transparency committee
insurance, health, reimbursement
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
bronchodilator agents
bronchodilator agents
treatment outcome
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
---
https://www.ema.europa.eu/medicines/human/EPAR/Brimica-Genuair
2014
false
United Kingdom
English
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
breast feeding
bronchodilator agents
bronchodilator agents
drug interactions
drug evaluation, preclinical
fertility
pregnancy
treatment outcome
drug approval
clinical trials, phase iii as topic
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/Duaklir-Genuair
2014
false
United Kingdom
English
French
drug combinations
aclidinium bromide
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
Formoterol Fumarate
Formoterol Fumarate
formoterol and aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
breast feeding
bronchodilator agents
bronchodilator agents
drug interactions
drug evaluation, preclinical
fertility
pregnancy
treatment outcome
drug approval
clinical trials, phase iii as topic
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---
http://www.has-sante.fr/portail/jcms/c_1528339/fr/eklira-genuair
2013
France
French
aclidinium bromide
aclidinium bromide
aclidinium bromide
administration, inhalation
pulmonary disease, chronic obstructive
adult
insurance, health, reimbursement
bronchodilator agents
bronchodilator agents
treatment outcome
randomized controlled trials as topic
evaluation of the transparency committee
forced expiratory volume
tropanes
tropanes
comparative study
---
Summary Basis of Decision (SBD) for Tudorza Genuair
Aclidinium bromide, 400 mcg, powder (metered dose), oral inhalation
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00198
2013
false
Canada
French
English
drug information
Product containing aclidinium (medicinal product)
aclidinium bromide
aclidinium bromide
aclidinium bromide
administration, inhalation
bronchodilator agents
bronchodilator agents
muscarinic antagonists
muscarinic antagonists
canada
drug approval
pulmonary disease, chronic obstructive
adult
aged
treatment outcome
tropanes
tropanes
---
https://minerva-ebp.be/fr/article/109
2013
false
false
minerva-ebm.be
Belgium
French
diagnostic uses of chemicals
Tiotropium Bromide
pulmonary disease, chronic obstructive
treatment outcome
critical appraisal or critical reading
tropanes
bronchodilator agents
aclidinium bromide
---
http://www.has-sante.fr/portail/jcms/c_1528336/fr/bretaris-genuair
2013
France
French
evaluation of the transparency committee
aclidinium bromide
aclidinium bromide
administration, inhalation
pulmonary disease, chronic obstructive
bronchodilator agents
bronchodilator agents
adult
insurance, health, reimbursement
treatment outcome
randomized controlled trials as topic
forced expiratory volume
tropanes
tropanes
aclidinium bromide
---
https://www.ema.europa.eu/medicines/human/EPAR/Bretaris-Genuair
2012
false
United Kingdom
English
French
aclidinium bromide
aclidinium bromide
tropanes
tropanes
administration, inhalation
adult
breast feeding
bronchodilator agents
bronchodilator agents
drug interactions
drug evaluation, preclinical
fertility
pregnancy
treatment outcome
drug approval
clinical trials, phase iii as topic
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
receptor, muscarinic m3
aclidinium bromide
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---